{"id":8386,"date":"2021-12-15T16:30:30","date_gmt":"2021-12-15T16:30:30","guid":{"rendered":"https:\/\/epitomestaging.com\/tnc\/?page_id=8386"},"modified":"2026-03-13T14:33:58","modified_gmt":"2026-03-13T14:33:58","slug":"fellowships","status":"publish","type":"page","link":"https:\/\/epitomestaging.com\/tnc\/fellowships\/","title":{"rendered":"Fellowships"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Home 2 Content Pg” _builder_version=”4.16″ background_color=”#bbe4ed” background_image=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/02\/rsz-tnc-header-scientists-1000×200-1.jpg” background_size=”initial” width_phone=”auto” width_last_edited=”off|desktop” max_width_last_edited=”off|desktop” module_alignment=”center” min_height_tablet=”300px” min_height_last_edited=”off|desktop” height=”200px” height_tablet=”154px” height_phone=”100px” height_last_edited=”on|phone” max_height_tablet=”300px” max_height_phone=”300px” max_height_last_edited=”off|desktop” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” top_divider_height_tablet=”” top_divider_height_phone=”50px” top_divider_height_last_edited=”on|phone” bottom_divider_style=”curve” bottom_divider_color=”#FFFFFF” bottom_divider_height=”70px” bottom_divider_arrangement=”above_content” bottom_divider_height_tablet=”70px” bottom_divider_height_phone=”50px” bottom_divider_height_last_edited=”on|desktop” background_last_edited=”on|phone” background_image_phone=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/02\/rsz-tnc-mobile-stars.jpg” background_enable_image_phone=”on” parallax_tablet=”off” parallax_phone=”off” background_size_tablet=”contain” background_size_phone=”initial” background_position_tablet=”top_center” background_position_phone=”top_right” module_alignment_tablet=”right” module_alignment_phone=”left” module_alignment_last_edited=”off|desktop” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ use_custom_gutter=”on” gutter_width=”1″ _builder_version=”4.16″ _module_preset=”default” module_alignment=”center” custom_margin=”0px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” z_index=”10″ custom_margin=”30px||||false|false” global_colors_info=”{}”]<\/p>\n

For Scientists<\/h1>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_enable_color=”off” custom_margin=”20px||20px||false|false” custom_padding=”0px||0px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”0px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Translational Neuroscience Fellowships<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_enable_color=”off” custom_padding=”0|0px|0|0|false|false” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.16″ custom_padding=”0px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” custom_padding=”0px||40px||false|” global_colors_info=”{}”]<\/p>\n

The Translational Neuroscience Center aims to help cultivate the next generation of translational scientists focused on childhood brain disorders by sponsoring fellowships for postdoctoral training.<\/p>\n

Rosamund Stone Zander Hansjoerg Wyss TNC Fellows<\/span><\/h3>\n

TNC Fellowship Applications are now closed for 2026.\u00a0<\/strong><\/span><\/p>\n

This multidisciplinary post-doctoral training program in translational research for neurodevelopmental disorders provides access to mentorship and resources across the Boston Children’s Hospital from clinicians and basic scientists, as well as collaborators from private industry and public not-for profit organizations. Fellows have opportunities for both preclinical and clinical research, and training in a broad set of skills to pursue independent translational research. Awardees pursue projects designed to facilitate the development of novel therapeutics.<\/p>\n

Please see our application guidelines here ><\/a>.<\/strong><\/p>\n

Neurodevelopmental T32 Fellows<\/h3>\n

T32 Fellowship Applications now closed for 2026.<\/strong><\/span><\/p>\n

The TNC coordinates the T32 Translational Postdoctoral Training in Neurodevelopment Fellowship Program at Boston Children\u2019s Hospital. Funded by the National Institute of Mental Health (NIMH), this fellowship supports researchers who aim to improve or expand their ability to conduct interdisciplinary investigation in translational neuroscience research in neurodevelopment and neurodevelopmental disorders. \u00a0The T32 program is led by two co-directors\u00a0 <\/span>(David Glahn<\/a>, PhD, Psychiatry; Charles Nelson<\/a>, PhD, Developmental Medicine Center) with a group of 19 highly skilled and successful training faculty from a diverse array of disciplines. The T32 Fellows will form a cohort with the RDCRN Fellowship Program and the NeuroNEXT Fellowship Program. New TNC and T32 Fellows will be recruited biannually and will be mentored through their fellowship training into positions within academia, clinical care and industry at the intersection of translational research for neurodevelopmental disorders.<\/span><\/p>\n

Fellows hold a joint appointment at Boston Children\u2019s Hospital and Harvard Medical School and enjoy access to the resources of both institutions.<\/p>\n

Please see our application guidelines<\/strong>\u00a0here ><\/a>.<\/strong><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/04\/tnc-fellows-raz.jpg” alt=”TNC fellows and Ms. Zander” title_text=”tnc fellows raz” _builder_version=”4.16.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Apply for Fellowships ><\/a><\/p>\n

[\/et_pb_text][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/04\/lisa-stephanie-winko.jpg” alt=”TNC leadership and fellow” title_text=”lisa stephanie winko” _builder_version=”4.16.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ background_enable_color=”off” custom_padding=”25px|0px|25px|0|false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

2025 Neurodevelopmental T32 Fellows<\/h2>\n

Two exceptional candidates have been awarded the Neurodevelopmental T32 post-doctoral fellowships from the Translational Neuroscience Center.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#bbe4ed” custom_padding=”0|0px|29px|0|false|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2026\/01\/Alcott_headshot-e1768421622262.png” alt=”Sanna Lokhandwala, PhD” title_text=”Alcott_headshot” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Callison <\/span>Alcott, MD, PhD<\/span><\/h3>\n

Dr. Alcott<\/span> completed his MD-PhD training at Baylor College of Medicine under the mentorship of Huda Zoghbi, during which he demonstrated that NUDT21<\/em> haploinsuffiency is associated with intellectual disability in humans, causes learning deficits in mice, and leads to misregulated alternative polyadenylation in human stem cell-derived neurons. He subsequently completed a combined pediatrics and child neurology residency at Boston Children\u2019s Hospital, where he is currently a behavioral neurology and neuropsychiatry fellow.<\/p>\n

His T32 fellowship project is to identify resting EEG biomarkers of neurodevelopmental disorders using machine learning. He is mentored by April Levin, MD, in the Department of Neurology at Boston Children\u2019s Hospital and Brandon Westover, MD, PhD in the Department of Neurology at Beth Israel Deaconess Medical Center.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#bbe4ed” custom_margin=”30px||||false|false” custom_padding=”0px||30px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2026\/01\/IMG_3355-scaled.jpg” alt=”Sanna Lokhandwala, PhD” title_text=”Bailey Holt-Gosselin Headshot” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Bailey Holt-Gosselin<\/span>, PhD<\/h3>\n

Dr. Holt-Gosselin completed her Ph.D. in Neuroscience at Yale University, where she identified neurobiological and environmental risk factors for psychopathology among youth at high familial risk for depression. Prior to Yale, she conducted research at Stanford University on brain mechanisms underlying depression and anxiety. Dr. Holt-Gosselin\u2019s research program aims to elucidate effects of caregiver-related early life adversity on brain development and mental health, and identify protective factors that buffer against poor outcomes. She is mentored by Dr. Charles Nelson at Boston Children\u2019s Hospital and Harvard Medical School.<\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ background_enable_color=”off” custom_padding=”25px|0px|25px|0|false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

2024 Neurodevelopmental T32 Fellows<\/h2>\n

Two exceptional candidates have been awarded the Neurodevelopmental T32 post-doctoral fellowships from the Translational Neuroscience Center.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ background_color=”#ededed” custom_margin=”||25px||false|false” custom_padding=”0px|0px|25px|0|false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2026\/01\/2021headshot2-scaled-e1768423291240.jpg” alt=”Chen_Ding_Headshot_400px_Square” title_text=”Kacie Dunham-Carr Headshot” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Kacie Dunham-Carr, PhD<\/h3>\n

Dr. Dunham-Carr received her PhD in Neuroscience from Vanderbilt University, where her doctoral research was funded by an F31 from the National Institutes of Health. Her research focuses on neural mechanisms of altered sensory processing as measured by electroencephalography (EEG) in autism. Her T32 work focuses on identifying EEG biomarkers of baseline neural circuit activity and sound processing differences in children with neurodevelopmental disorders. She is mentored by Dr. April Levin, as well as Dr. Chuck Nelson and Dr. Carol Wilkinson.\u00a0<\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ background_color=”#ededed” custom_margin=”||||false|false” custom_padding=”0|0px|25px|0|false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2026\/01\/EFS_pic.jpg” alt=”Wenkang \u201cWinko\u201d An” title_text=”Eileen Sullivan Headshot” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Eileen Sullivan, PhD<\/h3>\n

Dr. Sullivan earned her PhD in Human Development, Learning, and Teaching from the Harvard Graduate School of Education. Her doctoral studies employed neuroimaging techniques including EEG and fNIRS to investigate links among children\u2019s early adverse experiences, brain development, and cognitive outcomes. Eily\u2019s T32 fellowship is focused on examining the effects of nutrition and parenting programs on a wide range of developmental outcomes, as well as identifying early predictors of later cognitive outcomes. She is mentored by Dr. Charles A. Nelson within the Labs of Cognitive Neuroscience at Boston Children\u2019s Hospital.<\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ background_enable_color=”off” custom_padding=”25px|0px|25px|0|false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

2023 Neurodevelopmental T32 Fellows<\/h2>\n

Two exceptional candidates have been awarded the Neurodevelopmental T32 post-doctoral fellowships from the Translational Neuroscience Center.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#bbe4ed” custom_padding=”0|0px|29px|0|false|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2023\/06\/6.9.23-Sanna-Lokhandwala-400px-Headshot.jpg” alt=”Sanna Lokhandwala, PhD” title_text=”6.9.23 Sanna Lokhandwala 400px Headshot” _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Sanna Lokhandwala, PhD<\/h3>\n

Dr. Lokhandwala recently completed her PhD in Psychological & Brain Sciences at the University of Massachusetts, Amherst. Her work focuses on understanding the mechanistic role of sleep in brain development and cognitive function during early childhood. Sanna\u2019s T32 fellowship project aims to track the direction of and examine the relationship between the brain and sleep in adolescents. Furthermore, Dr. Lokhandwala is interested in examining how these trajectories may relate to psychopathology during this period in development. She is mentored by Drs. Maria Jalbrzikowski and Takao Hensch.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#bbe4ed” custom_margin=”30px||||false|false” custom_padding=”0px||30px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2024\/02\/Ruby-Lam-alt-e1706824411314.jpg” alt=”Sanna Lokhandwala, PhD” title_text=”Ruby Lam alt” _builder_version=”4.23.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.23.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Ruby Lam, PhD<\/h3>\n

Dr. Lam earned her PhD in neuroscience from Brown University as part of the graduate partnership program with the National Institute of Health. Throughout her doctoral studies, she conducted research on the cells and molecules involved in somatosensation under the guidance of Dr. Alexander Chesler. Her T32 fellowship is dedicated to understanding the neuromodulatory influences of Norepinephrine on sensory-motor phenotypes in rodent models of the neurodevelopmental disorder Rett syndrome.\u00a0 Dr. Lam is mentored by Dr. Mriganka Sur in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_enable_color=”off” custom_padding=”0|0px|29px|0|false|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

2023 Rosamund Stone Zander Hansjoerg Wyss TNC Fellows<\/span><\/h2>\n

These two outstanding candidates were chosen for their qualifications and ambitious research proposals. Each will have the opportunity to build translational research projects with the mentorship of leaders in their fields, and will leverage the full depth and breadth of resources at the TNC and BCH throughout their two-year fellowship program.<\/p>\n

 <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ background_color=”#ededed” custom_margin=”||25px||false|false” custom_padding=”0px|0px|25px|0|false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2023\/05\/Chen_Ding_Headshot_400px_Square.jpg” alt=”Chen_Ding_Headshot_400px_Square” title_text=”Chen_Ding_Headshot_400px_Square” _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Chen Ding, PhD<\/h3>\n

Dr. Ding recently completed his PhD in Neuroscience at Yale University, where he studied axon regeneration and axon degeneration in the model organism C. elegans<\/em> in the lab of Dr. Marc Hammarlund. During his PhD research, he became fascinated by the role of mitochondria in neurodegeneration. His fellowship project will focus on developing gene therapy approaches for autosomal dominant optic atrophy, a childhood disease caused by the important mitochondrial protein OPA1. His long-term career goal is to become an independent neuroscientist who accelerates the translation of basic research on neurodegenerative diseases to therapeutics. Dr. Ding is mentored by Dr. Thomas Schwarz in the Department of Neurobiology and the F.M. Kirby Neurobiology Center.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ background_color=”#ededed” custom_margin=”||||false|false” custom_padding=”0|0px|25px|0|false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2023\/05\/Sneham_Tiwari_Headshot_400px_Square.jpg” alt=”Wenkang \u201cWinko\u201d An” title_text=”Sneham_Tiwari_Headshot_400px_Square” _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Sneham Tiwari, PhD<\/h3>\n

Dr. Tiwari recently completed her PhD in Biomedical sciences at Herbert Wertheim College of Medicine at Florida International University. Her PhD focused on understanding aging-related neuropathologies and targeting them with efficient and bioavailable drug delivery systems. She is fascinated by understanding the neurological disorders and factors involved in the abnormal functioning of the brain and translation in patients\u2019 symptoms. Currently, she is a post-doctoral research fellow in the Department of Neurology at Boston Children\u2019s Hospital and Harvard Medical School, where she is pursuing her passion, studying epilepsy genetics with an emphasis on cellular mosaicism. Her fellowship project will be focused on studying somatic mutations occurring in genes of the mTOR pathway, targeting important genes that affect brain development. Her long-term career goal is to become an independent neuroscientist and focus on deciphering mechanisms underlying neurological disorders and translating towards high throughput drug screening and targeted efficient bioavailable therapeutics development to enhance patients\u2019 quality of life. Dr. Tiwari is mentored by Dr. Annapurna Poduri in the F.M. Kirby Neurobiology Center and Department of Neurology.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_enable_color=”off” custom_padding=”0|0px|29px|0|false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

2022 Neurodevelopmental T32 Fellows<\/h2>\n

Three outstanding candidates have been awarded the inaugural Neurodevelopmental T32 post-doctoral fellowships from the Translational Neuroscience Center.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#bbe4ed” custom_padding=”0|0px|29px|0|false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/07\/Duncan-Anna.jpg” alt=”Anna Duncan” title_text=”Duncan-Anna” _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Anna Duncan, MD<\/h3>\n

Dr. Duncan is a neonatologist at Massachusetts General for Children and an Instructor in Pediatrics at Harvard Medical School. She is an expert in neurodevelopmental disorders, with extensive previous work in developmental neurobiology, molecular genetics, embryology, and genetics.\u00a0<\/span>Her fellowship project aims to use zebrafish to examine how loss of KDM4B function alters neurodevelopment and behavior. Dr. Duncan is mentored by Dr. Annapurna Poduri of Boston Children\u2019s Hospital\u2019s Neurology department.<\/span>\u00a0<\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#bbe4ed” custom_margin=”30px||||false|false” custom_padding=”0px||30px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/07\/Haviland-Isabel.jpg” alt=”Isabel Haviland” title_text=”Haviland-Isabel” _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Isabel Haviland, MD<\/h3>\n

Dr. Haviland is a research fellow in the department of neurobiology of Boston Children\u2019s Hospital and Harvard Medical School, where she is focused on clinical research in CDKL5 deficiency disorder (CDD) and pediatric epilepsy genetics. She has participated in collaborations exploring treatment approaches to CDD and methods of precision diagnosis in neurodevelopmental disease and the high impact of genetic testing in this population. <\/span><\/p>\n

Her T32 fellowship is focused on expanding genotype-phenotype correlations in CDD and SCN2A-related disorders, two early-life developmental and epileptic encephalopathies with a wide spectrum of presentation. She is mentored by Dr. Heather Olson of Boston Children Hospital\u2019s Neurology department.\u00a0<\/span><\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#bbe4ed” custom_margin=”30px||||false|false” custom_padding=”0px||30px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2022\/07\/Vermudez-Sheryl-Anne.jpg” alt=”Sheryl Vermudez” title_text=”Vermudez-Sheryl-Anne” _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Sheryl-Anne Vermudez, PhD<\/h3>\n

Dr. Vermudez recently completed her PhD in pharmacology at Vanderbilt University and is currently a research fellow in the F.M. Kirby Neurobiology Center at Boston Children\u2019s Hospital investigating the role of Kv3.1 potassium channels in parvalbumin (PV) interneuron dysfunction and acquired epilepsy using an epileptogenic mouse fluid percussion model. <\/span><\/p>\n

Her T32 fellowship project aims to provide insights into the outstanding questions regarding mechanisms of and effective treatments for acquired epilepsy by understanding the role of Kv3.1 potassium channels and PV interneuron dysfunction, in turn elucidating KCNC1-mediated epilepsy and potential treatment strategies. Dr. Vermudez is co-mentored by Drs. Mustafa Sahin and Alexander Rotenberg of Boston Children\u2019s Hospital\u2019s Neurology department.\u00a0<\/span><\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.21.0″ background_enable_color=”off” custom_padding=”75px|0px|29px|0|false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

2021 Rosamund Stone Zander Hansjoerg Wyss TNC Fellows<\/span><\/h2>\n

Two extraordinary candidates have been awarded the first-ever post-doctoral fellowships from the Translational Neuroscience Center.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.17.6″ background_color=”#ededed” custom_margin=”||||false|false” custom_padding=”0|0px|29px|0|false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2021\/12\/An-Wenkang-300×300-1.jpg” alt=”Wenkang \u201cWinko\u201d An” title_text=”An-Wenkang-300×300″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Wenkang \u201cWinko\u201d An, PhD<\/h3>\n

Dr. An recently completed his PhD in Electrical and Computer Engineering at Carnegie Mellon University. He trained as an electrical and biomedical engineer with specializations in signal processing, machine learning and non-invasive neuroimaging methods. His long-term career goal is to become an independent developmental neuroscientist\/neuroengineer, studying the neural mechanisms underlying neurodevelopmental disorders. He hopes to develop diagnostic and treatment solutions using engineering concepts.<\/p>\n

His fellowship project applies advanced EEG signal processing in children with ASD related disorders. Dr. An is mentored by Drs. Charles Nelson and Carol Wilkinson from the Laboratories for Cognitive Neuroscience in the Department of Developmental Medicine.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.17.6″ background_color=”#ededed” custom_margin=”30px||||false|false” custom_padding=”0|0px|29px|0|false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/epitomestaging.com\/tnc\/wp-content\/uploads\/2021\/12\/Johnson-Kristina-300×300-1.jpg” alt=”Kristina \u201cKristy\u201d Teresa Johnson” title_text=”Johnson-Kristina-300×300″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Kristina \u201cKristy\u201d Teresa Johnson, PhD<\/h3>\n

Dr. Johnson completed her PhD in the MIT Media Lab during the summer of 2021. She worked at the intersection of neuroscience, engineering, and autism in the laboratory of Dr. Rosalind Picard. Her research experience includes multi-disciplinary techniques ranging from deep brain stimulation and fMRI neuroimaging to wearable biosensors and human-centered AI systems.<\/p>\n

Her fellowship project is focused on the integrated analysis of multi-modal data stemming from the Rare Disease Clinical Research Network Developmental Synaptopathies Consortium. Her long-term career goal is to accelerate research focused on improving the lives of individuals with complex neurodevelopmental differences, especially those who have few spoken words, genetic disorders, or intellectual disabilities. She is mentored by Dr. Mustafa Sahin in the Department of Neurology and Kirby Neurobiology Center.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”#ededed” custom_margin=”50px||||false|false” custom_padding=”0|0px|29px|0|false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”29px|0px|0|0px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text module_id=”t32app” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Fellowship Application Guidelines<\/h2>\n

[\/et_pb_text][et_pb_text module_id=”tncfellowapp” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

TNC Fellowship<\/a><\/h3>\n

2026 Application Cycle is now closed.<\/strong><\/span><\/p>\n

Applications should be submitted by\u00a0<\/span>February 9, 2026<\/strong>. An application should consist of the following documents listed below, in PDF format, to our\u00a0<\/span>Submittable application form:<\/span><\/a><\/p>\n